HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate-Palmolive Co.

www.colgate.com

Latest From Colgate-Palmolive Co.

Colgate Expects ‘Premiumization’ Of Oral Care To Boost North America Sales

Colgate says ‘premiumization’ of its oral care products in North America should drive improved product mix and pricing; higher-end offerings will include a recyclable Tom’s of Maine toothpaste tube and a Colgate Optic White offering. North American Q3 sales grew 1.2% to $869m.

OTC Drugs Sales & Earnings

Innovating Outside OTC Monograph Lines: Trending Acne Patches, Hand And Foot Antiperspirants

Industry and the FDA agree that the OTC drug monograph system is direly in need of reform, but innovating with noncompliant dosage forms and indications, without approved new drug applications, is a risk companies need to weigh seriously, says Arnall Golden Gregory partner Alan Minsk. The FDA offers perspective on its OTC monographs for acne and antiperspirant products.

United States Regulation

Health And Wellness Executive Decisions: CHPA Counsel, CRN SVP, Gellar For Colgate

CHPA appoints Anne Marie Murphy deputy general counsel; CRN promotes Andrew Wong to senior VP, scientific and regulatory affairs; and Sarah Michelle Gellar promotes the Colgate Optic White High Impact line.

Appointments Commercial

Wellness Market Executive Decisions: Beckham For Pedialyte, 'Gronk' For CBD, Honderd Out At Mary's, Appointments At GB Sciences, Nature's Bounty

Cleveland Browns' Beckham promotes Pedialyte for all; Pfizer consumer execTahiri heads Nature 's Bounty international business;GB Sciences adds cannabis operations expert; Honderd steps away at Mary's Brands; and 'Gronk' invests in CBD product firm, begins product development.

Dietary Supplements Appointments
See All

Company Information

UsernamePublicRestriction

Register